Skip to main content
Tech.euFundingExplorerBeta

GL Capital

Investor profile

Venture capital

GL Capital has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €68M. Most active in Healthtech. Data as of Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2022
1 yr
Total round €
€68M
sum of rounds joined

Deals by year

distinct rounds / year
GL Capital — deals by year — interactive chart.
Data table
GL Capital — deals by year
20221

Top sectors

by deals
GL Capital — top sectors — interactive chart.
Data table
GL Capital — top sectors
Healthtech1

Stages

by deals
GL Capital — stages — interactive chart.
Data table
GL Capital — stages
Series B1

Countries

by deals
GL Capital — countries — interactive chart.
Data table
GL Capital — countries
Switzerland1

Co-investment network

shared rounds
Co-investment network — interactive chart.
GL Capital — 1 dealsGL CapitalBioMedPartners — 1 shared deals · click to openBioMedPartnersFiscus Financial — 1 shared deals · click to openFiscus FinancialGIMV — 1 shared deals · click to openGIMVLightspeed Venture Partners — 1 shared deals · click to openLightspeed Venture PartnersMission BioCapital — 1 shared deals · click to openMission BioCapitalPeak6 Strategic Capital — 1 shared deals · click to openPeak6 Strategic CapitalPfizer Ventures — 1 shared deals · click to openPfizer VenturesSamsara Biocapital — 1 shared deals · click to openSamsara BiocapitalSchroder Adveq — 1 shared deals · click to openSchroder Adveq

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Immunos TherapeuticsSwitzerland1€68M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Immunos TherapeuticsSeries B€68M2022-06
← Back to investors